Display Settings:

Format

Send to:

Choose Destination
    Am J Hosp Palliat Care. 2006 Jan-Feb;23(1):35-40.

    Use of methylphenidate in patients with cancer.

    Source

    Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA.

    Abstract

    Cancer and its treatment are often associated with symptoms such as depression, somnolence, cognitive abnormalities, and fatigue. Methylphenidate, a stimulant medication, is commonly used to treat these symptoms. Several small pilot and a few adequately powered studies have assessed the safety and efficacy of methylphenidate in patients with cancer Overall, the studies so far suggest that methylphenidate is well-tolerated in patients with cancer Further, the studies have provided initial evidence of efficacy of this agent in patients with cancer The present article reviews the evidence base behind the use of methylphenidate in these patients.

    PMID:
    16450661
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk